Many people report noteworthy weight loss after the first 4 weeks of taking semaglutide, and they become more aware of their food intake and their body adjusts to the medication
New potential indications for GLP-1 agonist should be also investigated, such as insulin resistance, prediabetes and sarcopenia
Long-term commitment to Ozempic, including ongoing medical guidance and lifestyle changes, is essential for weight management
Most managers accommodate reasonable requests for flexibility during medical situations
In total, 3,808 participants took either semaglutide or a placebo for 156 weeks
As a result, many observers view these compounds as potentially complementary rather than directly competitive